Radiology - Technology Information Portal
Saturday, 18 May 2024
• Welcome to Radiology-TIP.com!
     • Sign in / Create account
 
 'Tomography' p12
SEARCH   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Searchterm 'Tomography' found in 6 terms [
] and 67 definitions [
]
Result Pages :
Optiray®
Optiray® is a radiographic contrast agent. Optiray® is available in concentrations from 160 to 350 mg/mL organically bound iodine. Optiray® solutions have osmolalities 1.2 to 2.8 times that of plasma (285 mOsm/kg water).
Optiray® 160 is recommended for intraarterial digital subtraction angiography (IA-DSA).
See also Single-Head Contrast Media Injector, Dual-Head CT Power Injector, Syringeless CT Power Injector.

Drug Information and Specification
NAME OF COMPOUND
Ioversol
DEVELOPER
Mallinckrodt, Inc.
INDICATION
Brain and body computed tomography, urography, angiography
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
Nonionic
355, 502, 651, 702, 792 mosm/kgH2O
IODINE CONCENTRATION
160, 240, 300, 320, 350 mg/mL
Depending on the used concentration and imaging procedure
PREPARATION
Ready-to-use product
STORAGE
Store at 25°C (77°F)
PRESENTATION
Depending on the concentration: 20, 30 mL vials, 50, 75, 100, 150, 200 mL bottles,
30, 50 mL prefilled hand held plastic syringes, and various power injector syringes (OptiVantage)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Oxilan®
Oxilan® is a radiographic contrast agent used in diagnostic imaging studies. The degree of contrast enhancement is directly related to the iodine content in the administered dose. Dependent on the iodine content, the osmolalities are 2.1 or 2.4 times that of plasma (285 mOsm/kg water).

Drug Information and Specification
NAME OF COMPOUND
Ioxilan
MANUFACTURER
INDICATION
Brain and body computed tomography, urography, angiography
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
Nonionic
585 and 695 mosm/kgH2O
IODINE CONCENTRATION
300 and 350 mg/mL
Depending on the used concentration and imaging procedure
PREPARATION
Ready-to-use product
STORAGE
Store between 15° - 30° Celsius (59° - 86° Fahrenheit)
PRESENTATION
50 mL, 100 mL, 150 mL, and 200 mL bottles
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Pitch
(p) The pitch (in computed tomography) is the ratio of the patient table increment to the total nominal beam width for the CT scan. The pitch factor relates the volume coverage speed to the thinnest sections that can be reconstructed. In spiral CT, dose is always inversely proportional to pitch.
Among the different manufacturers, there are various definitions of pitch depending on whether a single-detector (single-slice) or multi-detector (multi-slice) CT scanner is used.
For a single-slice helical scanner the pitch is:
Pitch = table movement per rotation/slice collimation.
The international standard formula (by the IEC) is:
Pitch = TF (table feed in mm per 360° rotation)/(N (number of detector rows) x SC (slice collimation in mm))
Pitch Factor
The pitch factor is a selectable CT parameter. The definition depending on the IEC standards is the ratio of the table speed per rotation and the total collimation.
The choice of pitch factor is determined on practical considerations and on the availability of the computed tomography algorithms and parameters for image reconstruction.

See Pitch.
Positron
A positron is a positively charged, with a resting energy of at least 511 keV, subatomic particle. A positron is the antiparticle of an electron, identical in mass and spin.
Positrons can be generated by positron decay or pair production.
Positron emission tomography detects positrons from the decay of radioactive tracers.

See also Beta Decay.
Result Pages :
 
Share This Page
Facebook
Twitter
LinkedIn
Look
      Ups
Radiology - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging
Copyright © 2008 - 2024 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2023-11-06 02:01:00]